Corporate Overview

IPA's proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in IPA, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.

Learn more

Latest News

Latest Events

View All
View All